Literature DB >> 3519005

Hormonal and cardiovascular responses to DDAVP in man.

T D Williams, S L Lightman, M J Leadbeater.   

Abstract

Hormonal and cardiovascular responses to 1-desamino-8-D-arginine vasopressin (DDAVP) were investigated in six normal adult volunteers. After overnight fluid deprivation, an intravenous injection of either DDAVP (0.4 microgram/kg) or the same volume of normal saline was administered. One hour later an intravenous infusion of hypertonic saline was commenced and continued over two hours. Five minutes following the DDAVP injection, facial flushing, a fall in diastolic blood pressure by an average of 13% and a rise in pulse rate by an average of 18% were observed. There was a significant increase in plasma renin activity and plasma cortisol concentration, but no significant changes were observed in plasma concentrations of LH, FSH, TSH, prolactin or GH. Following osmotic stimulation by hypertonic saline plasma AVP rose to the same extent in both the DDAVP and control studies. DDAVP (0.4 microgram/kg) was also administered to five subjects with cranial diabetes insipidus. Again facial flushing, increased facial temperature, a fall in diastolic pressure and a rise in heart rate were all observed, suggesting that DDAVP exerts its cardiovascular actions by a mechanism other than antagonism of circulating endogenous AVP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519005     DOI: 10.1111/j.1365-2265.1986.tb03258.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Long-term treatment of nocturnal enuresis with desmopressin. A follow-up study.

Authors:  U B Knudsen; S Rittig; J P Nørgaard; J B Lundemose; E B Pedersen; J C Djurhuus
Journal:  Urol Res       Date:  1991

Review 2.  Spontaneous compartment syndrome in a patient with diabetes insipidus.

Authors:  G Geutjens
Journal:  Int Orthop       Date:  1994-02       Impact factor: 3.075

3.  Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.

Authors:  D P Brooks; P F Koster; F L Stassen; C R Albrightson; W F Huffman; M A Wasserman; L B Kinter
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

4.  Antihaemophilic effect of vasopressin, deamino-(D-arginine8)-vasopressin and adrenaline in sheep: proposal for an in vivo assay system.

Authors:  J Heiniger; L Kissling-Albrecht; S Neuenschwander; R Rösli; V Pliska
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.